» Articles » PMID: 16873695

Insulin Regulation of Skeletal Muscle PDK4 MRNA Expression is Impaired in Acute Insulin-resistant States

Overview
Journal Diabetes
Specialty Endocrinology
Date 2006 Jul 29
PMID 16873695
Citations 61
Authors
Affiliations
Soon will be listed here.
Abstract

We previously showed that insulin has a profound effect to suppress pyruvate dehydrogenase kinase (PDK) 4 expression in rat skeletal muscle. In the present study, we examined whether insulin's effect on PDK4 expression is impaired in acute insulin-resistant states and, if so, whether this change is accompanied by decreased insulin's effects to stimulate Akt and forkhead box class O (FOXO) 1 phosphorylation. To induce insulin resistance, conscious overnight-fasted rats received a constant infusion of Intralipid or lactate for 5 h, while a control group received saline infusion. Following the initial infusions, each group received saline or insulin infusion (n = 6 or 7 each) for an additional 5 h, while saline, Intralipid, or lactate infusion was continued. Plasma glucose was clamped at basal levels during the insulin infusion. Compared with the control group, Intralipid and lactate infusions decreased glucose infusion rates required to clamp plasma glucose by approximately 60% (P < 0.01), confirming the induction of insulin resistance. Insulin's ability to suppress PDK4 mRNA level was impaired in skeletal muscle with Intralipid and lactate infusions, resulting in two- to threefold higher PDK4 mRNA levels with insulin (P < 0.05). Insulin stimulation of Akt and FOXO1 phosphorylation was also significantly decreased with Intralipid and lactate infusions. These data suggest that insulin's effect to suppress PDK4 gene expression in skeletal muscle is impaired in insulin-resistant states, and this may be due to impaired insulin signaling for stimulation of Akt and FOXO1 phosphorylation. Impaired insulin's effect to suppress PDK4 expression may explain the association between PDK4 overexpression and insulin resistance in skeletal muscle.

Citing Articles

Hypoxia-induced signaling in the cardiovascular system: pathogenesis and therapeutic targets.

Zhao Y, Xiong W, Li C, Zhao R, Lu H, Song S Signal Transduct Target Ther. 2023; 8(1):431.

PMID: 37981648 PMC: 10658171. DOI: 10.1038/s41392-023-01652-9.


FoxO1 as a tissue-specific therapeutic target for type 2 diabetes.

Teaney N, Cyr N Front Endocrinol (Lausanne). 2023; 14:1286838.

PMID: 37941908 PMC: 10629996. DOI: 10.3389/fendo.2023.1286838.


Glucose-lowering effects of a synbiotic combination containing Pediococcus acidilactici in C. elegans and mice.

Yavorov-Dayliev D, Milagro F, Ayo J, Oneca M, Goyache I, Lopez-Yoldi M Diabetologia. 2023; 66(11):2117-2138.

PMID: 37584728 PMC: 10542285. DOI: 10.1007/s00125-023-05981-w.


Bioinformatics Analysis of Next Generation Sequencing Data Identifies Molecular Biomarkers Associated With Type 2 Diabetes Mellitus.

Alur V, Raju V, Vastrad B, Vastrad C, Kavatagimath S, Kotturshetti S Clin Med Insights Endocrinol Diabetes. 2023; 16:11795514231155635.

PMID: 36844983 PMC: 9944228. DOI: 10.1177/11795514231155635.


The Link between Mitochondrial Dysfunction and Sarcopenia: An Update Focusing on the Role of Pyruvate Dehydrogenase Kinase 4.

Kim M, Sinam I, Siddique Z, Jeon J, Lee I Diabetes Metab J. 2023; 47(2):153-163.

PMID: 36635027 PMC: 10040620. DOI: 10.4093/dmj.2022.0305.